Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > PP Closed
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(664)
•••
Comment by DeathXray33on Sep 08, 2023 10:29am
241 Views
Post# 35626021

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:PP Closed

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:PP Closed
Oilminerdeluxe wrote: So this money will last 2-3 months? Either very good news is coming then or very bad ones. One would think they should be able to raise more if that was indeed needed? Or no one is interested at all to participate. But with such solid results... Ahh... the paranoia inside me will never calm down. The application for BTD might perhaps have been sent now then. Fingers crossed.

Exciting times.


A while back; a friend of mine died of lung cancer only 6 weeks after being diagnosed. His wife has breast cancer and they support 3 little girls. Mr. Joe Biden's son died of cancer. This anti-cancer technology has great efficacy, superior safety and doesn't discriminate. Why wouldn't they give us BTD, AA or FR, etc... I'm buying more Monday. I'm supporting this company the best I can.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities